Indeed, perturbation of YTHDF1 by gene silencing averted resistance to anti-PD1 therapy by inhibiting MDSC infiltration and boosting cytotoxic CD8 functions in MMRp-positive CRC (166). This evidence concerns the gene CD8A and colorectal carcinoma.